Sign in
4

Changes in Ownership

10x Genomics, Inc. Filed Acc 0001209191-21-020874

Director sold 41,666 shares at an average $156.98 ($6,540,905)

  • Director acquired 41,666 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hindson Benjamin J. · Director

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2021-03-12 Exercise or conversion : show line 1 in the form +36,364 $0.88 $32,000 73,000 D
2021-03-12 Exercise or conversion : show line 2 in the form +5,302 $1.07 $5,673 78,302 D
2021-03-12 Sale : show line 3 in the form −6,023 $154.56 $930,887 72,279 D
2021-03-12 Sale : show line 4 in the form −8,074 $155.54 $1,255,815 64,205 D
2021-03-12 Sale : show line 5 in the form −8,189 $156.45 $1,281,143 56,016 D
2021-03-12 Sale : show line 6 in the form −5,845 $157.48 $920,452 50,171 D
2021-03-12 Sale : show line 7 in the form −6,368 $158.64 $1,010,223 43,803 D
2021-03-12 Sale : show line 8 in the form −7,167 $159.40 $1,142,386 36,636 D
Open-market sales · 41,666 sh · avg $156.98 · $6,540,905

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2021-03-12 Exercise or conversion : show line 9 in the form Stock Option (right to buy) −36,364 $0.88 2025-10-27 36,364 0 D
2021-03-12 Exercise or conversion : show line 10 in the form Stock Option (right to buy) −5,302 $1.07 2026-11-18 5,302 119,698 D
Loading xslF345X03/doc4.xml…